Acquisition by Bent Christine of 82143 shares of InnovAge Holding subject to Rule 16b-3
| INNV Stock | USD 3.78 0.09 2.44% |
Slightly above 54% of InnovAge Holding's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading InnovAge Holding Corp stock suggests that some investors are interested at this time. InnovAge Holding's investing sentiment can be driven by a variety of factors including economic data, InnovAge Holding's earnings reports, geopolitical events, and overall market trends.
InnovAge |
Filed transaction by Innovage Holding Corp officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
InnovAge Holding Fundamental Analysis
We analyze InnovAge Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InnovAge Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InnovAge Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
InnovAge Holding is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
InnovAge Holding Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InnovAge Holding stock to make a market-neutral strategy. Peer analysis of InnovAge Holding could also be used in its relative valuation, which is a method of valuing InnovAge Holding by comparing valuation metrics with similar companies.
Peers
InnovAge Holding Related Equities
| ENSG | Ensign | 1.79 | ||||
| EHC | Encompass Health | 1.39 | ||||
| EHAB | Enhabit | 1.17 | ||||
| PNTG | Pennant | 0.87 | ||||
| SEM | Select Medical | 0.48 | ||||
| NHC | National HealthCare | 0.44 | ||||
| MODV | ModivCare | 0.64 | ||||
| CCEL | CryoCell International | 4.52 |
Additional Tools for InnovAge Stock Analysis
When running InnovAge Holding's price analysis, check to measure InnovAge Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnovAge Holding is operating at the current time. Most of InnovAge Holding's value examination focuses on studying past and present price action to predict the probability of InnovAge Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnovAge Holding's price. Additionally, you may evaluate how the addition of InnovAge Holding to your portfolios can decrease your overall portfolio volatility.